Intervention Review

You have free access to this content

Antenatal immunoglobulin for fetal red blood cell alloimmunization

  1. Kae Sheen Wong1,*,
  2. Kirsten Connan2,
  3. Shelley Rowlands2,
  4. Louise H Kornman3,
  5. Helen F Savoia4

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 31 MAY 2013

Assessed as up-to-date: 13 DEC 2012

DOI: 10.1002/14651858.CD008267.pub2


How to Cite

Wong KS, Connan K, Rowlands S, Kornman LH, Savoia HF. Antenatal immunoglobulin for fetal red blood cell alloimmunization. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD008267. DOI: 10.1002/14651858.CD008267.pub2.

Author Information

  1. 1

    The Royal Women's Hospital, Department of Obstetrics and Gynaecology, Parkville, Victoria, Australia

  2. 2

    The Royal Women's Hospital, Department of Perinatal Medicine, Parkville, Victoria, Australia

  3. 3

    The University of Melbourne, The Royal Women's Hospital, Melbourne, Victoria, Australia

  4. 4

    Royal Children's Hospital, Laboratory Services, Parkville, Victoria, Australia

*Kae Sheen Wong, Department of Obstetrics and Gynaecology, The Royal Women's Hospital, Corner of Grattan Street and Flemington Road, Parkville, Victoria, 3052, Australia. kaewong@optusnet.com.au.

Publication History

  1. Publication Status: New
  2. Published Online: 31 MAY 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jacqueline Kerr, Isabella Quinti, Martha Eibl, Helen Chapel, Peter J. Späth, W. A. Carrock Sewell, Abdulgabar Salama, Ivo N. van Schaik, Taco W. Kuijpers, Hans-Hartmut Peter, Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe, Frontiers in Immunology, 2014, 5,

    CrossRef

  2. 2
    Farheen Karim, Bushra Moiz, Nausheen Kamran, Risk of maternal alloimmunization in Southern Pakistan – A study in a cohort of 1000 pregnant women, Transfusion and Apheresis Science, 2014,

    CrossRef